MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.anl.2023.04.006

Медицинская библиотека · Auris, nasus, larynx · 2023

Comprehensive Genome profile testing in head and neck cancer.

Kuroki Masashi, Iinuma Ryota, Okuda Hiroshi, Terazawa Kosuke, Shibata Hirofumi, Mori Ken-Ichi, Ohashi Toshimitsu, Makiyama Akitaka, Futamura Manabu, Miyazaki Tatsuhiko, Horikawa Yukio, Ogawa Takenori

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

Head and neck cancer (HNC) is a tumor occurring in various primary sites with limited chemotherapy options for its treatment. Recently, comprehensive genomic profiling (CGP) testing has become clinically widespread. In this study, we examined the utility of CGP in diagnosing and treating HNC.

METHODS

This study included 29 patients with HNC who underwent CGP testing at the Gifu University Hospital between December 2019 and April 2022. We analyzed the types of gene mutations and tumor mutational burden (TMB) based on the CGP results. Squamous cell carcinoma accounted for 55.2%, and other cancers accounted for 44.8%. And we investigated the correlation of prognosis with gene mutations and TMB.

RESULTS

Gene mutations were detected in TP53(48.3%), CDKN2A (27.6%), CDKN2B (17.2%), NOTCH1 (17.2%), PIK3CA (17.2%), ARID1A (13.8%), and NF1 (13.8%). TP53, CDKN2A and CDKN2B mutations significantly decreased survival rate in HNC. Five cases (17.2%) were TMB-high and 82.8% were TMB-low. In SCC cases treated with immune checkpoint inhibitors, TMB-high had better Overall survival than TMB-low. And all patients with TMB-high were oropharyngeal cancer.

CONCLUSION

Although there were no cases in which effective treatment was actually performed based on the results of CGP, many gene mutations have been detected and several gene mutations correlated with prognosis. Furthermore, TMB can be used as a biomarker to predict the therapeutic effects of immune checkpoint inhibitors in cases of SCC.

Для цитирования: Kuroki Masashi, Iinuma Ryota, Okuda Hiroshi, Terazawa Kosuke, Shibata Hirofumi, Mori Ken-Ichi, Ohashi Toshimitsu, Makiyama Akitaka, Futamura Manabu, Miyazaki Tatsuhiko, Horikawa Yukio, Ogawa Takenori. Comprehensive Genome profile testing in head and neck cancer.. Auris, nasus, larynx. 2023. DOI: 10.1016/j.anl.2023.04.006.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.